Du (督) Three Needles Combined with Hand & Foot Luan (挛) Three Needles in the Treatment of Myotonia During Early-Mid Stage Parkinson's Disease: A Randomized Controlled Trial
|更新时间:2022-08-25
|
Du (督) Three Needles Combined with Hand & Foot Luan (挛) Three Needles in the Treatment of Myotonia During Early-Mid Stage Parkinson's Disease: A Randomized Controlled Trial
Journal of Traditional Chinese MedicineVol. 63, Issue 17, Pages: 1662-1667(2022)
FAN Jingqi,LU Weijing,WANG Yuting,et al.Du (督) Three Needles Combined with Hand & Foot Luan (挛) Three Needles in the Treatment of Myotonia During Early-Mid Stage Parkinson's Disease: A Randomized Controlled Trial[J].Journal of Traditional Chinese Medicine,2022,63(17):1662-1667.
FAN Jingqi,LU Weijing,WANG Yuting,et al.Du (督) Three Needles Combined with Hand & Foot Luan (挛) Three Needles in the Treatment of Myotonia During Early-Mid Stage Parkinson's Disease: A Randomized Controlled Trial[J].Journal of Traditional Chinese Medicine,2022,63(17):1662-1667.DOI: 10.13288/j.11-2166/r.2022.17.012.
Du (督) Three Needles Combined with Hand & Foot Luan (挛) Three Needles in the Treatment of Myotonia During Early-Mid Stage Parkinson's Disease: A Randomized Controlled Trial
(挛) three needles in the treatment of myotonic symptoms in patients with early-mid stage Parkinson's di-sease (PD), as well as the the possible mechanism.
Methods
2
Totally, 120 early-mid stage PD patients with myptonia were randomized into treatment group (60 cases) and control group (60 cases). Maintaining the dose of the original anti-PD drugs, the treatment group was given
Du
three needles at
Dazhui
(DU 14),
Jinsuo
(DU 8) and
Mingmen
(DU 4), in combination with hand
Luan
three needles at Jiquan (HT 1), Chize (LU 5) and Neigua (PC 6) in terms of upper limb myotonia, and foot
Luan
three needles at
Shuxi
, Yinlingquan (SP 9) and Sanyinjiao (SP 6) for lower limb myotonia, using lifting and thrusting method, with even supplementation and drainage. The control group was treated with sham acupuncture on the basis of the same dose of the original anti-PD drugs. Both groups were treated four times a week for eight weeks. The United Parkinson's Disease Rating Scale Part Ⅲ (UPDRS Ⅲ) motor examination score, the myotonia score by UPDRS Ⅲ, 10-meter walk test, and Ashworth scale score were assessed, and serum α-synuclein (α-syn) and brain-derived neurotrophic factor (BDNF) levels were detected before and after treatment. The clinical effect was defined, and the adverse events during treatment were recorded.
Results
2
During the study, six cases in the control group and two cases in the treatment group were dropped out. Finally, 58 cases in the treatment group and 54 cases in the control group were included in the analysis. After treatment, the UPDRS Ⅲ motor examination score, the myotonia score by UPDRS Ⅲ, the Ashworth scale score and 10-meter walking time in the treatment group significantly decreased, while the 10-meter walking speed and serum BDNF level significantly increased (
P
<0.05 or
P
<0.01); there was no significant differences in above mentioned outcomes before and after treatment in the control group (
P
>0.05). For 10-meter walking stride and serum α-syn level, there were no significant differences before and after treatment in both groups (
P
>0.05). The total effective rate in the treatment group was 67%, significantly higher than 26% in the control group (
P
<0.05). There were no serious adverse events in both groups during the treatment.
Conclusion
2
The application of
Du
three needles combined with hand
&
foot
Luan
three needles can improve the myotonia symptoms, reduce the limb spasm, and improve motor function in early-mid stage PD patients, and the mechanism may be related to promoting the production of endogenous BDNF.
关键词
Keywords
references
GBD 2019 Ageing Collaborators . Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study [J]. BMJ , 2022 , 376 : e68208 . doi: 10.1136/bmj-2021-068208 http://dx.doi.org/10.1136/bmj-2021-068208 .
POSTUMA RB , BERG D , STERN M , et al . MDS clinical diagnostic criteria for Parkinson's disease [J]. Movement Disorders , 2015 , 30 ( 12 ): 1591 - 1601 .
DEVOS D , HIRSCH E , WYSE R . Seven solutions for neuroprotection in Parkinson's disease [J]. Mov Disord , 2021 , 36 ( 2 ): 306 - 316 .
JANKOVIC J . Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations [J]. Mov Disord , 2005 , Suppl 11 : S11 - S16 . doi: 10.1002/mds. 20458 http://dx.doi.org/10.1002/mds.20458 .
WEN X , LI K , WEN H , et al . Acupuncture-related therapies for Parkinson's disease: a meta-analysis and qualitative review [J]. Front Aging Neurosci , 2021 , 13 : 676827 . doi: 10.3389/fnagi.2021.676827 http://dx.doi.org/10.3389/fnagi.2021.676827 .
HUANG J , QIN X , CAI X , et al . Effectiveness of acupuncture in the treatment of Parkinson's disease: an overview of systematic reviews [J]. Front Neurol , 2020 , 11 : 917 . doi: 10.3389/fneur.2020.00917 http://dx.doi.org/10.3389/fneur.2020.00917 .
XIAO D . Acupuncture for Parkinson's disease: a review of clinical, animal, and functional magnetic resonance imaging studies [J]. J Tradit Chin Med , 2015 , 35 ( 6 ): 709 - 717 .
AMATACHAYA S , KWANMONGKOLTHONG M , THONGJUMROON A , et al . Influence of timing protocols and distance covered on the outcomes of the 10-meter walk test [J]. Physiother Theory Pract , 2020 , 36 ( 12 ): 1348 - 1353 .
DUFFY MF , COLLIER TJ , PATTERSON JR , et al . Quality over quantity: advantages of using alpha-synuclein preformed fibril triggered synucleinopathy to model idiopathic Parkinson's disease [J]. Front Neurosci , 2018 , 12 : 621 . doi: 10.3389/fnins.2018.00621 http://dx.doi.org/10.3389/fnins.2018.00621 .
DE PABLO-FERNÁNDEZ E , LEES AJ , HOLTON JL , et al . Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease [J]. JAMA Neurol , 2019 , 76 ( 4 ): 470 - 479 .
WANG Q , LIU J , GUO Y , et al . Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis [J]. Braz J Med Biol Res , 2019 , 52 ( 8 ): e8443 .
Parkinson's Disease Myotonia Treated with Du Mai Three-needle Therapy
Professor ZHOU Shaohua's Experience in Staged Treatment of Parkinson's Disease Based on the "Disease-Symptom-Syndrome Integration" Approach
Ganye Pingchan Decoction (感夜平颤方) for Patients with Early-Moderate Parkinson's Disease Complicated with Rapid Eye Movement Sleep Behavior Disorder on Sleep and Blood Pressure Circadian Rhythm Disorders: A Randomized Controlled Trial
Effects of Bushen Zhichan Formula (补肾止颤方) on Ferroptosis of Dopaminergic Neurons and Nrf2-Regulated SLC7A11/GSH/GPX4 Signaling Pathway in Parkinson's Disease Model Rats
Effect of Bushen Huoxue Granule (补肾活血颗粒) on Dopamine Homeostasis and ERK/CREB/VMAT2 Signaling Pathways in the Striatum in Parkinson's Disease Model Mice
Related Author
CHEN Yuanyuan
FAN Jingqi
LU Weijing
TAN Weiqiang
YAN Mingyue
LI Yingjia
ZHUANG Lixing
XU Dinglin
Related Institution
Clinical Medical College of Acupuncture Moxibustion and Rehabilitation,Guangzhou University of Chinese Medicine
Graduate School,Beijing University of Chinese Medicine
Xiyuan Hospital,China Academy of Chinese Medical Sciences
School of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine